Neuro Gum & Mints

Functional chewing gum and mints for energy, focus, calm, and cognitive support, distributed DTC and retail.

Cover Block

PUBLIC

Attribute	Value
Company Name	Neuro Gum & Mints (GetNeuro)
Tagline	Functional chewing gum and mints for energy, focus, calm, and cognitive support, distributed DTC and retail.
Headquarters	Las Vegas, United States
Founded	2015
Stage	Other
Business Model	Direct-to-Consumer (DTC)
Industry	E-commerce / Retail
Technology	No Technology Component
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Executive Summary

PUBLIC Neuro Gum & Mints has built a nine-figure revenue business by selling science-backed, functional chewing gum and mints directly to consumers and through national retail chains, demonstrating a rare bootstrapped growth trajectory in the crowded wellness space [neurogum.com]. Founded in 2015 by lifelong friends Kent Yoshimura and Ryan Chen, the company emerged from the founders' personal search for a clean, convenient alternative to coffee and energy drinks [neurogum.com]. The core product line, which includes Energy & Focus, Calm & Clarity, and Sleep & Recharge formulas, differentiates itself through specific, clinically relevant doses of ingredients like caffeine, L-theanine, and GABA, delivered in a sugar-free, aspartame-free format [innerbody.com].

While the company's appearance on Shark Tank in Season 11 provided a significant visibility boost, the deal did not close, and Neuro has since scaled largely through revenue funding and strategic retail expansion [Instagram]. Multiple secondary sources report monthly revenue averaging $10 million, with a projected annual run rate of approximately $120 million for 2026 [inc.com, celebinfomgz.com]. The founding team combines a creative, athletic background with operational focus, though their public record does not include prior consumer packaged goods exits. Over the next 12-18 months, the key watchpoints are the sustainability of retail velocity against established competitors, the defensibility of its formulation-based wedge, and whether the company pursues institutional capital to accelerate its next phase of growth. Data Accuracy: YELLOW -- Revenue figures are widely cited but not from primary financial statements; founding story and product details are confirmed by company sources.

Taxonomy Snapshot

Axis	Value
Stage	Other
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	E-commerce / Retail
Technology Type	No Technology Component
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Company Overview

PUBLIC Neuro Gum & Mints began as a personal project between two lifelong friends, Kent Yoshimura and Ryan Chen, who launched the company in 2015 [neurogum.com]. The founding narrative centers on their shared experience as high-performing athletes and creatives seeking a clean, reliable source of functional energy and focus, which they could not find in the existing market for sugary gums or jitter-inducing energy drinks [neurogum.com]. The company is headquartered in Las Vegas, Nevada, and operates under the legal name NeuroGum, Inc. [lvgea.org].

A pivotal moment for the brand came in 2019 with its appearance on Season 11 of the television show Shark Tank [neurogum.com]. While a deal was not ultimately closed, the national exposure is cited as a catalyst for significant retail expansion [neurogum.com]. Following this, Neuro secured distribution in major U.S. retail chains, including CVS, Walmart, Whole Foods, and Target, establishing its omni-channel presence [neurogum.com].

As of the latest public data, the company reports having between 51 and 200 employees [LinkedIn]. Its growth trajectory, from a direct-to-consumer startup to a nationally distributed brand, has been largely fueled by revenue and strategic retail partnerships rather than through widely disclosed venture capital rounds. Data Accuracy: GREEN -- Confirmed by company website, LinkedIn, and state economic development documentation.

Product and Technology

MIXED

Neuro's core proposition is a straightforward one: to deliver functional ingredients through a convenient, fast-absorbing oral format. The company's product line is segmented by intended cognitive effect, with each SKU built around a specific combination of nootropics and adaptogens. The Energy & Focus variants combine caffeine and L-theanine, a pairing common in the nootropic space for its potential to smooth the stimulant's edge. The Calm & Clarity line uses GABA and related ingredients, while the Ideal State mints are formulated with melatonin and L-theanine for sleep support [innerbody.com]. The company emphasizes that its formulations are sugar-free, aspartame-free, and vegan, a clean-label positioning aimed at health-conscious consumers [neurogum.com].

Beyond ingredient selection, the primary technological or product differentiator is the delivery system itself. Chewing gum and mints allow for sublingual absorption, which the company suggests provides a steadier, more controlled release of active compounds compared to the rapid spike and crash associated with coffee or energy drinks [neurogum.com]. The product is positioned as a portable, on-demand tool for cognitive modulation. The company provides specific dosage information for key ingredients, such as 60-65 mg of L-theanine in its Energy & Focus gum and 130 mg of GABA in its Calm & Clarity gum, grounding its marketing in quantified, clinically-relevant amounts [innerbody.com].

There is no public evidence of proprietary technology related to manufacturing, formulation, or delivery. The business appears to be a classic consumer packaged goods (CPG) play, with differentiation rooted in brand, formulation science, and retail execution rather than a defensible technical moat. The company's website and marketing materials do not describe a public product roadmap or upcoming technological innovations.

Data Accuracy: GREEN -- Product details and claims are confirmed by the company's own website and independent review publications.

Market Research

PUBLIC The functional gum and mint category has emerged as a discrete segment within the broader wellness and cognitive enhancement market, driven by a consumer shift towards convenient, fast-acting alternatives to traditional supplements and beverages.

Quantifying the total addressable market for functional gum specifically is challenging, as most third-party research groups the product within larger categories like dietary supplements or functional foods. The global dietary supplements market was valued at approximately $177 billion in 2023, with the cognitive health supplement sub-segment representing a significant and growing portion [Grand View Research, 2024]. Within this, the functional gum niche is an analog to the energy shot and ready-to-drink nootropic beverage segments, which have seen sustained growth. The company's primary market, the United States, is the largest single market for dietary supplements, accounting for roughly a third of global sales [Nutrition Business Journal, 2023].

Demand for products like Neuro's is propelled by several concurrent tailwinds. The mainstreaming of biohacking and nootropic use, once confined to niche communities, has created a broader audience for cognitive support products. A growing aversion to sugar and artificial sweeteners, particularly aspartame, aligns with Neuro's formulation claims. Furthermore, the post-pandemic emphasis on mental wellness and stress management has expanded the addressable market for products promoting calm and focus. The convenience factor of a gum or mint, which requires no preparation and offers rapid buccal absorption, is a key differentiator from pills or powders, appealing to on-the-go professionals, students, and athletes.

Key adjacent and substitute markets include the energy drink sector, valued at over $90 billion globally [Statista, 2024], and the broader functional beverage category. These are the primary competitive arenas from which Neuro aims to capture share by offering a sugar-free, jitter-free alternative. The regulatory environment, governed by the FDA's Dietary Supplement Health and Education Act (DSHEA), presents both a framework and a risk. While it allows for the sale of supplements containing ingredients like GABA and L-theanine, the company bears responsibility for ensuring product safety and label compliance. Macro forces such as inflation in shipping and ingredient costs can pressure margins, though the company's retail partnerships may provide some scale advantages.

Given the lack of a directly cited TAM for functional gum, the following table presents analogous market sizing data for relevant adjacent categories, based on third-party reports.

Market Segment	Estimated Size (2023/2024)	Source
Global Dietary Supplements Market	$177 billion	[Grand View Research, 2024]
Global Energy Drinks Market	$90+ billion	[Statista, 2024]
U.S. Cognitive Health Supplements	$4+ billion (estimated)	[Nutrition Business Journal, 2023]

The data underscores the substantial pools of consumer spending Neuro is targeting. The company's wedge is not to create a new market but to capture a meaningful slice of existing, large markets by offering a superior format and cleaner ingredient profile. Success hinges on convincing consumers to switch from established beverage habits to a chewable format, a significant but plausible behavioral shift given broader wellness trends.

Data Accuracy: YELLOW -- Market sizing is based on analogous third-party reports for adjacent categories; no specific TAM for functional gum was located in cited sources.

Competitive Landscape

MIXED

Neuro's competitive position is defined by a sharp focus on science-backed, functional gum and mints, a format that separates it from the broader beverage and supplement markets it indirectly targets. The company operates in a fragmented segment populated by small specialists and adjacent products from large consumer packaged goods companies.

A comparison of key functional gum players illustrates the core competitive set.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Neuro Gum & Mints	Science-backed, nootropic gum/mints for energy, focus, calm; zero sugar, aspartame-free, vegan.	Undisclosed; $8.3M seed reported (2023).	Omni-channel retail distribution (CVS, Walmart, Whole Foods); founder-led brand narrative tied to athletic performance and neuroscience.	[neurogum.com]
Run Gum	Energy gum for athletes, containing caffeine and B-vitamins.	Private; founder-funded.	Strong association with elite track & field; simple, performance-focused branding.	[Public]
Viter Energy	Caffeinated mints and gum, marketed as a coffee alternative.	Private.	Focus on high caffeine content per piece; positioned as a direct coffee replacement.	[Public]
Military Energy Gum	Caffeine gum developed for and marketed to military personnel.	Private.	Niche focus on military and first responders; specific use-case branding.	[Public]
WUG Functional Gums	Functional gum with ingredients like vitamins, caffeine, and melatonin.	Private.	Broad functional claims across wellness; often found in discount and online channels.	[Public]

The competitive map breaks into three tiers. At the direct product level, Neuro contends with other functional gum brands like Run Gum and Viter Energy. These competitors often emphasize a single benefit, such as raw energy or alertness, with simpler formulations. Neuro's edge here is its segmented product line targeting distinct cognitive states, supported by specific ingredient dosages it highlights as clinically relevant [innerbody.com]. The adjacent substitute tier is far larger, comprising energy drinks, coffee, and traditional supplement pills. Neuro's wedge against these substitutes is format and experience: a portable, sugar-free, fast-acting delivery system that promises to avoid the jitters and crash associated with many beverages [neurogum.com]. The third tier consists of potential entrants from large CPG conglomerates, which currently have limited dedicated offerings in the functional gum niche but possess overwhelming scale in distribution and marketing.

Neuro's most defensible edge today is its retail footprint. Securing shelf space in national chains like CVS, Walmart, and Whole Foods represents a significant barrier to entry for newer brands and provides a durable revenue channel [neurogum.com]. This distribution advantage is perishable, however, if velocity slows or if a competitor secures exclusive agreements. A second, softer edge is the founders' personal brand narrative, which blends athletic discipline, artistic creativity, and an interest in biohacking. This narrative has been effective in generating media attention and consumer trust, though it is harder to quantify and scale than physical distribution.

The company's primary exposure lies in its relatively narrow product surface area. While it has successfully expanded from gum into mints and across several functional categories, it remains a single-brand company within a specific format. A competitor with a broader wellness portfolio could bundle functional gum with other products or use cross-promotional power. Neuro is also exposed to ingredient sourcing and regulatory scrutiny common to the supplement industry, where claims are closely watched. Furthermore, its DTC channel, while successful, competes directly with Amazon, where many of its competitors also sell and where price competition can intensify.

The most plausible 18-month scenario is one of continued segmentation. The functional gum category is likely to support multiple winners serving different consumer sub-segments. The winner in this scenario is the brand that best translates retail presence into loyal, repeat purchase behavior, moving beyond novelty to staple status. For Neuro, this would mean deepening its relationship with existing retail partners and expanding its product line within the gum and mint format. The loser would be a brand that fails to move beyond a single hero product or that gets outmaneuvered on supply chain efficiency, leading to margin pressure as the category becomes more crowded. Neuro's reported revenue scale suggests it is currently ahead in the race for staple status, but that lead requires constant reinforcement [inc.com, 2026].

Data Accuracy: YELLOW -- Competitor data is based on public company positioning; funding and scale details for private competitors are not widely disclosed. Neuro's retail distribution is confirmed by its own materials.

Opportunity

PUBLIC If Neuro can convert its early retail velocity into a durable, brand-led consumer habit, the prize is a dominant position in a multi-billion dollar functional consumables category.

The headline opportunity is to become the default, on-the-go nootropic for the mass market, displacing a portion of daily coffee and energy drink consumption with a more convenient and consistent format. The company's path to this outcome is reachable, not merely aspirational, because of its established national retail footprint. Neuro products are already on shelves at CVS, Walmart, Whole Foods, and Target [neurogum.com], providing a critical proof point for consumer demand and supply chain execution. This shelf space, secured without traditional venture capital backing according to multiple sources [founderoo.co][celebhilights.com], demonstrates a foundational wedge into mainstream consumer packaged goods (CPG). The company's reported monthly revenue of approximately $10 million [inc.com, 2026] suggests the initial product-market fit is translating at scale, providing a financial base to fund the brand-building and product line expansion necessary to capture a larger share of mind.

Growth from this base could follow several concrete scenarios, each with identifiable catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Retail Channel Dominance	Neuro becomes the top-selling functional gum in major drug and grocery chains, commanding premium shelf placement and expanded SKU counts.	A successful launch in a new, high-volume retail category like convenience stores or mass merchandisers.	The brand has already proven it can secure and maintain distribution in complex national retailers [neurogum.com]. Category growth for functional foods and supplements supports ongoing buyer interest.
International Expansion	The company replicates its U.S. DTC and retail model in key international markets, first in English-speaking regions then in Europe and Asia.	A strategic partnership with a global distributor or a regional CPG player to navigate local regulations and supply chains.	The product's format is globally portable, and the wellness positioning has broad cross-cultural appeal. Early DTC shipping provides demand signal before committing to physical retail abroad.
Adjacent Category Launch	Neuro leverages its brand trust and "functional fuel" positioning to launch adjacent consumable formats, such as dissolvable strips, quick-stick packets, or ready-to-drink beverages.	The introduction of a second major product form factor that addresses a new usage occasion (e.g., pre-workout, sleep).	The founders' narrative emphasizes creating solutions for "energy, focus, and cognitive support" [neurogum.com], a platform positioning that logically extends beyond gum and mints.

The compounding advantage for Neuro, should one of these scenarios gain traction, is a classic CPG flywheel driven by brand recognition and retail use. Initial retail wins provide cash flow, which funds increased marketing and consumer education. Greater brand awareness drives higher velocity (sales per store per week), which in turn gives Neuro more negotiating power with retailers for better placement and terms. This improved retail performance then funds further product innovation and market expansion, creating a virtuous cycle. There is early evidence this flywheel is beginning to spin; the company's appearance on Shark Tank provided a national awareness boost [instagram.com], and its subsequent retail expansion suggests that awareness converted into sufficient demand to attract major chain buyers [neurogum.com].

Quantifying the size of the win requires looking at comparable public companies in the adjacent wellness and functional beverage space. Celsius Holdings, a maker of fitness-focused energy drinks, reached a market capitalization of approximately $20 billion at its peak, demonstrating the valuation potential of a brand that successfully carves out a high-growth niche within the massive beverage category. While Neuro operates in a different format, its addressable market is similarly the daily consumption habits of health-conscious adults. If the Retail Channel Dominance scenario plays out, Neuro could plausibly achieve a valuation reflecting a meaningful share of the functional gum and mint segment, which itself is a subset of the larger energy and cognitive supplement market. A conservative, scenario-based estimate (not a forecast) could see the company valued at a mid-single-digit multiple of its revenue, which, if it sustains reported figures, places it in the range of several hundred million dollars. A more ambitious outcome, akin to Celsius's trajectory, would require capturing a defining role in a new category of functional consumables.

Data Accuracy: YELLOW -- Growth scenarios and market size are analyst projections. The foundational revenue and retail distribution claims are supported by multiple publications, though specific financials are not from audited statements.

Sources